Dr. Paul Benson, MD (he/him) is a Dermatologist in Johnson City, TN with over 21 years of experience. What is your opinion of Dr. Paul Benson, MD? Rate this provider below so other people can make informed decision.
Gender
Male (Approximately 80% of Dermatologists in Johnson City, TN are Male)
Education
Tulane University School of Medicine, 1978
Degree Type
MD (Approximately 90% of Dermatologists in Johnson City, TN have MD degree)
Medical Specialties
Dermatologist (There are 10 Dermatologists available in Johnson City, TN, which is 59% more than the average number of Dermatologists in similar U.S. locations)
Experience
21+ Years of Experience (About 16% more than the average Dermatologist in Johnson City, TN)
Languages Spoken
English
Common Conditions
Based on the training and education, Dr. Paul Benson, MD may treat patients with the following conditions. Please always check with Dr. Paul Benson, MD directly about which exact conditions he treats.
Based on the training and education, Dr. Paul Benson, MD may perform the following treatments. Please always check with Dr. Paul Benson, MD directly about which exact treatments he offers.
Juvederm
Radiesse
Liquid Facelift
Thermage
Non-Surgical Nose Job
Research Publications
Approximately 50% of Dermatologists in Johnson City, TN have available research publications
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.
Erkki Lathouwers, Eric Y Wong, Kimberley Brown, Bryan Baugh, Anne Ghys, John Jezorwski, El Ghazi Mohsine, Erika Van Landuyt, Magda Opsomer, Sandra De Meyer, AMBER and EMERALD Study Groups
AIDS research and human retroviruses 2019-10-21
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1.
Joseph J Eron, Chloe Orkin, Douglas Cunningham, Federico Pulido, Frank A Post, Stéphane De Wit, Erkki Lathouwers, Veerle Hufkens, John Jezorwski, Romana Petrovic, Kimberley Brown, Erika Van Landuyt, Magda Opsomer, EMERALD study group
Antiviral research 2019-07-04
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial.
Chloe Orkin, Jean-Michel Molina, Eugenia Negredo, José R Arribas, Joseph Gathe, Joseph J Eron, Erika Van Landuyt, Erkki Lathouwers, Veerle Hufkens, Romana Petrovic, Simon Vanveggel, Magda Opsomer, EMERALD study group
The lancet. HIV 2017-10-06
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Paul E Sax, David Wohl, Michael T Yin, Frank Post, Edwin DeJesus, Michael Saag, Anton Pozniak, Melanie Thompson, Daniel Podzamczer, Jean Michel Molina, Shinichi Oka, Ellen Koenig, Benoit Trottier, Jaime Andrade-Villanueva, Gordon Crofoot, Joseph M Custodio, Andrew Plummer, Lijie Zhong, Huyen Cao, Hal Martin, Christian Callebaut, Andrew K Cheng, Marshall W Fordyce, Scott McCallister, GS-US-292-0104/0111 Study Team
Lancet (London, England) 2015-04-15
A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection.
Naomi E Aronson, Glenn W Wortmann, William R Byrne, Robin S Howard, Wendy B Bernstein, Mary A Marovich, Mark E Polhemus, In-Kyu Yoon, Kelly A Hummer, Robert A Gasser, Charles N Oster, Paul M Benson
PLoS neglected tropical diseases 2010-03-09
The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing first-line treatment regimen selection.
H-Y Huang, E S Daar, P E Sax, B Young, P Cook, P Benson, C Cohen, A Scribner, H Hu
HIV medicine 2008-05
Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options.
Robert J Willard, Anelia M Jeffcoat, Paul M Benson, Douglas S Walsh
Journal of the American Academy of Dermatology 2005-06
What is your diagnosis? Solitary mastocytoma.
Amy Y Paul, Naomi Creel, Paul M Benson
Cutis 2004-10
Safety of oral versus intravenous hydration during induction therapy with intravenous foscarnet in AIDS patients with cytomegalovirus infections.
T W Cheung, D T Jayaweera, D Pearce, P Benson, R Nahass, C Olson, G M Wool
International journal of STD & AIDS 2000-10
Deep dermal granuloma annulare presenting as an eyelid tumor in a child, with review of pediatric eyelid lesions.
Do you have any questions about plastic surgery, dermatology and cosmetic dentistry treatments? You can now post those questions in SelectWow Forum and have our experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of questions, all for FREE! Register today and join the conversation!
Get Directions
Call: (423) 929-7546
